Berman Capital Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $509K | Buy |
3,728
+1,780
| +91% | +$243K | 0.08% | 131 |
|
2021
Q2 | $206K | Buy |
1,948
+1,324
| +212% | +$140K | 0.03% | 228 |
|
2021
Q1 | $56K | Buy |
624
+36
| +6% | +$3.23K | 0.01% | 439 |
|
2020
Q4 | $53K | Sell |
588
-204
| -26% | -$18.4K | 0.01% | 399 |
|
2020
Q3 | $81K | Buy |
792
+228
| +40% | +$23.3K | 0.02% | 256 |
|
2020
Q2 | $57K | Buy |
564
+36
| +7% | +$3.64K | 0.02% | 302 |
|
2020
Q1 | $35K | Buy |
528
+136
| +35% | +$9.02K | 0.01% | 360 |
|
2019
Q4 | $21K | Sell |
392
-40
| -9% | -$2.14K | 0.01% | 517 |
|
2019
Q3 | $16K | Buy |
432
+92
| +27% | +$3.41K | 0.01% | 566 |
|
2019
Q2 | $12K | Buy |
340
+36
| +12% | +$1.27K | ﹤0.01% | 664 |
|
2019
Q1 | $9K | Buy |
304
+116
| +62% | +$3.43K | ﹤0.01% | 683 |
|
2018
Q4 | $5K | Buy |
+188
| New | +$5K | ﹤0.01% | 677 |
|